Cargando…

Blood–brain barrier permeability measured using dynamic contrast‐enhanced magnetic resonance imaging: a validation study

KEY POINTS: The blood–brain barrier (BBB) is an important and dynamic structure which contributes to homeostasis in the central nervous system. BBB permeability changes occur in health and disease but measurement of BBB permeability in humans is not straightforward. Dynamic contrast‐enhanced magneti...

Descripción completa

Detalles Bibliográficos
Autores principales: Varatharaj, Aravinthan, Liljeroth, Maria, Darekar, Angela, Larsson, Henrik B.W., Galea, Ian, Cramer, Stig P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355631/
https://www.ncbi.nlm.nih.gov/pubmed/30417928
http://dx.doi.org/10.1113/JP276887
_version_ 1783391351311695872
author Varatharaj, Aravinthan
Liljeroth, Maria
Darekar, Angela
Larsson, Henrik B.W.
Galea, Ian
Cramer, Stig P.
author_facet Varatharaj, Aravinthan
Liljeroth, Maria
Darekar, Angela
Larsson, Henrik B.W.
Galea, Ian
Cramer, Stig P.
author_sort Varatharaj, Aravinthan
collection PubMed
description KEY POINTS: The blood–brain barrier (BBB) is an important and dynamic structure which contributes to homeostasis in the central nervous system. BBB permeability changes occur in health and disease but measurement of BBB permeability in humans is not straightforward. Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) can be used to model the movement of gadolinium contrast into the brain, expressed as the influx constant K (i). Here evidence is provided that K (i) as measured by DCE‐MRI behaves as expected for a marker of overall BBB leakage. These results support the use of DCE‐MRI for in vivo studies of human BBB permeability in health and disease. ABSTRACT: Blood–brain barrier (BBB) leakage can be measured using dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) as the influx constant K (i). To validate this method we compared measured K (i) with biological expectations, namely (1) higher K (i) in healthy individual grey matter (GM) versus white matter (WM), (2) GM/WM cerebral blood volume (CBV) ratio close to the histologically established GM/WM vascular density ratio, (3) higher K (i) in visibly enhancing multiple sclerosis (MS) lesions versus MS normal appearing white matter (NAWM), and (4) higher K (i) in MS NAWM versus healthy individual NAWM. We recruited 13 healthy individuals and 12 patients with MS and performed whole‐brain 3D DCE‐MRI at 3 T. K (i) and CBV were calculated using Patlak modelling for manual regions of interest (ROI) and segmented tissue masks. K (i) was higher in control GM versus WM (P = 0.001). CBV was higher in GM versus WM (P = 0.005, mean ratio 1.9). K (i) was higher in visibly enhancing MS lesions versus MS NAWM (P = 0.002), and in MS NAWM versus controls (P = 0.014). Bland–Altman analysis showed no significant difference between ROI and segmentation methods (P = 0.638) and an intra‐class correlation coefficient showed moderate single measure consistency (0.610). K (i) behaves as expected for a compound marker of permeability and surface area. The GM/WM CBV ratio measured by this technique is in agreement with the literature. This adds evidence to the validity of K (i) measured by DCE‐MRI as a marker of overall BBB leakage.
format Online
Article
Text
id pubmed-6355631
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63556312019-02-07 Blood–brain barrier permeability measured using dynamic contrast‐enhanced magnetic resonance imaging: a validation study Varatharaj, Aravinthan Liljeroth, Maria Darekar, Angela Larsson, Henrik B.W. Galea, Ian Cramer, Stig P. J Physiol Techniques for Physiology KEY POINTS: The blood–brain barrier (BBB) is an important and dynamic structure which contributes to homeostasis in the central nervous system. BBB permeability changes occur in health and disease but measurement of BBB permeability in humans is not straightforward. Dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) can be used to model the movement of gadolinium contrast into the brain, expressed as the influx constant K (i). Here evidence is provided that K (i) as measured by DCE‐MRI behaves as expected for a marker of overall BBB leakage. These results support the use of DCE‐MRI for in vivo studies of human BBB permeability in health and disease. ABSTRACT: Blood–brain barrier (BBB) leakage can be measured using dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) as the influx constant K (i). To validate this method we compared measured K (i) with biological expectations, namely (1) higher K (i) in healthy individual grey matter (GM) versus white matter (WM), (2) GM/WM cerebral blood volume (CBV) ratio close to the histologically established GM/WM vascular density ratio, (3) higher K (i) in visibly enhancing multiple sclerosis (MS) lesions versus MS normal appearing white matter (NAWM), and (4) higher K (i) in MS NAWM versus healthy individual NAWM. We recruited 13 healthy individuals and 12 patients with MS and performed whole‐brain 3D DCE‐MRI at 3 T. K (i) and CBV were calculated using Patlak modelling for manual regions of interest (ROI) and segmented tissue masks. K (i) was higher in control GM versus WM (P = 0.001). CBV was higher in GM versus WM (P = 0.005, mean ratio 1.9). K (i) was higher in visibly enhancing MS lesions versus MS NAWM (P = 0.002), and in MS NAWM versus controls (P = 0.014). Bland–Altman analysis showed no significant difference between ROI and segmentation methods (P = 0.638) and an intra‐class correlation coefficient showed moderate single measure consistency (0.610). K (i) behaves as expected for a compound marker of permeability and surface area. The GM/WM CBV ratio measured by this technique is in agreement with the literature. This adds evidence to the validity of K (i) measured by DCE‐MRI as a marker of overall BBB leakage. John Wiley and Sons Inc. 2018-11-29 2019-02-01 /pmc/articles/PMC6355631/ /pubmed/30417928 http://dx.doi.org/10.1113/JP276887 Text en © 2018 The Authors. The Journal of Physiology published by John Wiley & Sons Ltd on behalf of The Physiological Society This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Techniques for Physiology
Varatharaj, Aravinthan
Liljeroth, Maria
Darekar, Angela
Larsson, Henrik B.W.
Galea, Ian
Cramer, Stig P.
Blood–brain barrier permeability measured using dynamic contrast‐enhanced magnetic resonance imaging: a validation study
title Blood–brain barrier permeability measured using dynamic contrast‐enhanced magnetic resonance imaging: a validation study
title_full Blood–brain barrier permeability measured using dynamic contrast‐enhanced magnetic resonance imaging: a validation study
title_fullStr Blood–brain barrier permeability measured using dynamic contrast‐enhanced magnetic resonance imaging: a validation study
title_full_unstemmed Blood–brain barrier permeability measured using dynamic contrast‐enhanced magnetic resonance imaging: a validation study
title_short Blood–brain barrier permeability measured using dynamic contrast‐enhanced magnetic resonance imaging: a validation study
title_sort blood–brain barrier permeability measured using dynamic contrast‐enhanced magnetic resonance imaging: a validation study
topic Techniques for Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6355631/
https://www.ncbi.nlm.nih.gov/pubmed/30417928
http://dx.doi.org/10.1113/JP276887
work_keys_str_mv AT varatharajaravinthan bloodbrainbarrierpermeabilitymeasuredusingdynamiccontrastenhancedmagneticresonanceimagingavalidationstudy
AT liljerothmaria bloodbrainbarrierpermeabilitymeasuredusingdynamiccontrastenhancedmagneticresonanceimagingavalidationstudy
AT darekarangela bloodbrainbarrierpermeabilitymeasuredusingdynamiccontrastenhancedmagneticresonanceimagingavalidationstudy
AT larssonhenrikbw bloodbrainbarrierpermeabilitymeasuredusingdynamiccontrastenhancedmagneticresonanceimagingavalidationstudy
AT galeaian bloodbrainbarrierpermeabilitymeasuredusingdynamiccontrastenhancedmagneticresonanceimagingavalidationstudy
AT cramerstigp bloodbrainbarrierpermeabilitymeasuredusingdynamiccontrastenhancedmagneticresonanceimagingavalidationstudy